
Investor Relations Captor Therapeutics ®
Shareholders
Shareholder | Total number of shares | Total number of votes | Percentage of share capital | Percentage of total votes at the GSM | |
---|---|---|---|---|---|
1. | Michał Walczak | 933 528 | 1 473 545 | 16,89% | 22,09% |
2. | Paweł Holstinghausen-Holsten | ||||
directly | 363 186 | 723 261 | 6,57% | 10,83% | |
indirectly via the Holstinghausen-Holsten Family Foundation | 236 112 | 236 1112 | 4,27% | 3,54% | |
total | 599 298 | 959 373 | 10,84% | 14,37% | |
3. | Sylvain Cottens | 340 897 | 526 730 | 6,17% | 7,89% |
4. | TFI Allianz Polska S.A. | 343 483 | 343 483 | 6,21% | 5,14% |
5. | Funds Managed by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 303 075 | 303 075 | 5,48% | 4,54% |
6. | Others | 2 975 290 | 3 035 758 | 54,41% | 45,97% |
Total | 5 528 709 | 6 676 102 | 100,00% | 100,00% |